Circulating Clinical Strains of Human Parainfluenza Virus Reveal Viral Entry Requirements for In Vivo Infection

Interaction between the Hemagglutinin-Neuraminidase and Fusion Glycoproteins of Human Parainfluenza Virus Type III Regulates Viral Growth In Vivo

(2013) R. Xu et al.   mBio

Regulation of Paramyxovirus Fusion Activation: the Hemagglutinin-Neuraminidase Protein Stabilizes the Fusion Protein in a Pretriggered State

(2012) M. Porotto et al.   JOURNAL OF VIROLOGY

Adaptation of Human Parainfluenza Virus to Airway Epithelium Reveals Fusion Properties Required for Growth in Host Tissue

(2012) S. G. Palmer et al.   mBio

Symptomatic Parainfluenza Virus Infections in Children Undergoing Hematopoietic Stem Cell Transplantation

(2011) Ashok Srinivasan et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A parainfluenza-3 outbreak in a SCT unit: sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortality

(2011) A Hodson et al.   BONE MARROW TRANSPLANTATION

Treatment of Parainfluenza 3 Infection With DAS181 in a Patient After Allogeneic Stem Cell Transplantation

(2011) Y.-B. Chen et al.   CLINICAL INFECTIOUS DISEASES

Influenza pharmacotherapy: present situation, strategies and hopes

(2011) Paolo Preziosi   EXPERT OPINION ON PHARMACOTHERAPY

Mechanism of Fusion Triggering by Human Parainfluenza Virus Type III

(2011) Matteo Porotto et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Spring-Loaded Model Revisited: Paramyxovirus Fusion Requires Engagement of a Receptor Binding Protein beyond Initial Triggering of the Fusion Protein

(2011) M. Porotto et al.   JOURNAL OF VIROLOGY

Human parainfluenza virus type 3 (HPIV 3) viral community-acquired pneumonia (CAP) mimicking swine influenza (H1N1) during the swine flu pandemic

(2010) Burke A. Cunha et al.   HEART & LUNG

A Recombinant Sialidase Fusion Protein Effectively Inhibits Human Parainfluenza Viral Infection In Vitro and In Vivo

(2010) Anne Moscona et al.   JOURNAL OF INFECTIOUS DISEASES

Design of a Potent D-Peptide HIV-1 Entry Inhibitor with a Strong Barrier to Resistance

(2010) B. D. Welch et al.   JOURNAL OF VIROLOGY

Viral Entry Inhibitors Targeted to the Membrane Site of Action

(2010) M. Porotto et al.   JOURNAL OF VIROLOGY

A Quantitative and Kinetic Fusion Protein-Triggering Assay Can Discern Distinct Steps in the Nipah Virus Membrane Fusion Cascade

(2010) H. C. Aguilar et al.   JOURNAL OF VIROLOGY

Inhibition of Nipah Virus Infection In Vivo: Targeting an Early Stage of Paramyxovirus Fusion Activation during Viral Entry

(2010) Matteo Porotto et al.   PLoS Pathogens

Control of an Outbreak of Human Parainfluenza Virus 3 in Hematopoietic Stem Cell Transplant Recipients

(2009) Richard T. Maziarz et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Human Parainfluenza Virus Infection of the Airway Epithelium: Viral Hemagglutinin-Neuraminidase Regulates Fusion Protein Activation and Modulates Infectivity

(2009) L. M. Palermo et al.   JOURNAL OF VIROLOGY

Kinetic Dependence of Paramyxovirus Entry Inhibition

(2009) M. Porotto et al.   JOURNAL OF VIROLOGY

Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency

(2009) P. Ingallinella et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Asymmetric Deactivation of HIV-1 gp41 following Fusion Inhibitor Binding

(2009) Kristen M. Kahle et al.   PLoS Pathogens

Viral membrane fusion

(2008) Stephen C Harrison   NATURE STRUCTURAL & MOLECULAR BIOLOGY